Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,20720,854,0.97 [0.91-1.03],0.2998264102110324
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,20670,167,0.88 [0.76-1.01],0.0695351674720802
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22361,167,0.98 [0.85-1.13],0.8144066726819967
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,15761,639,0.95 [0.88-1.02],0.159158417330398
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22303,109,0.88 [0.74-1.05],0.1562224036883275
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21424,74,0.90 [0.73-1.10],0.302633207372333
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23507,108,0.89 [0.75-1.06],0.1856394608385336
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23500,71,0.97 [0.78-1.20],0.761538649412217
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,20884,50,0.90 [0.70-1.17],0.437575035882273
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,22956,104,0.96 [0.80-1.15],0.6676864670170075
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other septicaemia,22916,64,0.86 [0.69-1.08],0.1987985676243682
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23573,68,1.00 [0.80-1.25],0.9757683472581844
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other viral diseases,23548,83,0.93 [0.76-1.13],0.4619195514316389
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23545,80,0.92 [0.75-1.13],0.4411459182902731
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Mycoses,23255,59,1.01 [0.79-1.28],0.9554495422722644
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22567,370,0.94 [0.85-1.03],0.1964258781736346
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22311,114,0.91 [0.77-1.08],0.2769477989127133
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22454,257,0.98 [0.87-1.10],0.6704192789297074
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",19272,46,0.90 [0.69-1.18],0.4488991515728125
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19281,55,nan [nan-nan],
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19455,229,1.02 [0.90-1.16],0.7334210779656973
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19462,236,1.02 [0.90-1.15],0.7805807070776977
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",19801,575,0.97 [0.89-1.05],0.4108145882568677
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19271,45,0.90 [0.69-1.19],0.460362185302919
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,21163,873,1.02 [0.96-1.09],0.4696754258427097
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22664,250,1.08 [0.96-1.22],0.2068963415723302
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23271,95,1.00 [0.83-1.22],0.9661534175839336
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23653,82,1.08 [0.87-1.33],0.4862303100273907
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Rectum,23473,54,1.34 [1.03-1.75],0.0310560118314245
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23655,58,0.90 [0.71-1.13],0.3613287161233725
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Stomach,23697,44,0.96 [0.73-1.26],0.7632476591064329
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign lipomatous neoplasm,23509,240,0.94 [0.84-1.06],0.316437930808316
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23654,98,0.91 [0.76-1.10],0.3401441154653846
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23653,90,0.92 [0.76-1.11],0.3801647529598446
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23590,61,0.97 [0.77-1.23],0.8198146829873165
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Haemangioma, any site",23592,60,0.99 [0.78-1.25],0.915857557445408
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Melanocytic naevi,23508,231,1.09 [0.96-1.23],0.1830523059111209
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,23657,109,1.28 [1.06-1.54],0.0113030984745795
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Other benign neoplasms of skin,23564,195,1.12 [0.97-1.28],0.1122387075682301
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm of breast,23642,120,0.97 [0.82-1.15],0.7497740028973712
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Leiomyoma of uterus,23212,870,0.99 [0.93-1.06],0.7498137484706282
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22525,238,1.05 [0.93-1.18],0.4691053652522792
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22293,375,1.06 [0.96-1.16],0.2790308603747704
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22293,375,1.06 [0.96-1.16],0.2790308603747704
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),20983,338,0.94 [0.85-1.04],0.2019466516538326
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23187,83,0.88 [0.72-1.07],0.1901347601173129
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23404,83,0.95 [0.77-1.16],0.5922244406060158
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,19704,753,1.02 [0.95-1.10],0.5001415414557778
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,21740,760,1.02 [0.95-1.09],0.5921269999612201
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,22113,97,0.86 [0.72-1.04],0.1154837821032181
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Peripheral artery disease,22812,47,1.00 [0.76-1.31],0.9827522257379128
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22103,87,0.88 [0.73-1.07],0.2095056583606103
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,22361,345,1.05 [0.95-1.17],0.366759387581794
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22351,335,1.05 [0.94-1.17],0.387472937712873
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,21938,164,0.93 [0.80-1.09],0.3602153344846233
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",21940,161,0.94 [0.80-1.10],0.4166286276231852
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,19539,588,1.02 [0.94-1.11],0.5919312923857345
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",19017,66,1.05 [0.83-1.33],0.6905603170374746
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,19499,548,1.02 [0.94-1.10],0.7042207249939099
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,18999,48,1.08 [0.82-1.42],0.5974416227410255
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",19009,58,0.91 [0.71-1.15],0.4231243449979687
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Any mental disorder,19987,515,1.00 [0.92-1.09],0.9995360561224828
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19568,96,0.88 [0.73-1.06],0.1850176078012189
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23481,61,0.83 [0.66-1.05],0.1265306197237729
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23517,36,0.74 [0.55-1.00],0.0538808913673793
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Acute alcohol intoxication,22445,31,0.93 [0.66-1.29],0.6517124246741544
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",23653,31,0.92 [0.66-1.28],0.6145592402227977
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",19503,31,0.93 [0.67-1.30],0.6701638418324333
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Alcohol dependence,22435,21,0.68 [0.46-1.00],0.0520786144929129
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Smoking dependency,22355,31,0.82 [0.59-1.14],0.2470090054137385
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19510,38,0.99 [0.73-1.34],0.9287914206037896
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19788,316,1.01 [0.91-1.12],0.852236770474748
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Depression,21979,282,1.00 [0.90-1.12],0.9719655352493812
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Depression or dysthymia,19609,244,1.04 [0.92-1.17],0.5584356184586253
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19600,128,1.09 [0.92-1.29],0.3302513284747373
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Other anxiety disorders,22050,65,0.92 [0.73-1.15],0.4680850204119247
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Neurological diseases,20508,1392,1.01 [0.96-1.07],0.5982296486211284
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18760,158,1.03 [0.88-1.19],0.7268973566146266
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23525,129,1.03 [0.87-1.21],0.7383488615535339
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22570,364,0.97 [0.88-1.07],0.5195089984726392
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Epilepsy,22319,113,0.87 [0.74-1.03],0.1118606640411221
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Migraine,22315,109,1.04 [0.87-1.24],0.6754205689497363
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23317,102,1.05 [0.87-1.26],0.6269726828931748
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Transient ischemic attack,23101,50,1.20 [0.91-1.58],0.1928300806073585
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other sleep disorders,22294,88,0.94 [0.77-1.15],0.5490829889524627
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Sleep apnoea,23342,62,1.01 [0.80-1.28],0.9440538334673164
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22503,721,1.01 [0.94-1.08],0.8194431338814676
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21886,104,1.04 [0.86-1.24],0.7002684298910353
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22236,454,1.02 [0.94-1.12],0.6029358464262922
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23475,65,1.15 [0.91-1.46],0.2532633621314963
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Hemiplegia,23458,48,1.05 [0.80-1.38],0.7312642634703121
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other neurological diseases,23279,101,0.90 [0.75-1.08],0.2536165754895235
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23064,372,0.97 [0.88-1.07],0.5546006541522819
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22905,213,1.02 [0.90-1.16],0.7656846772572286
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22755,63,0.84 [0.67-1.06],0.1365384797667734
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22803,111,1.09 [0.91-1.30],0.3681116018896251
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22785,93,1.03 [0.84-1.25],0.7908473726301397
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,20100,145,0.92 [0.79-1.08],0.3035178984403427
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20311,356,1.01 [0.91-1.11],0.8863724620872455
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22809,153,0.97 [0.83-1.12],0.6615439502088787
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23479,28,0.88 [0.62-1.24],0.4583516222094101
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1530,28,0.86 [0.61-1.21],0.3767130058791604
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",21977,28,0.89 [0.63-1.25],0.4858766902714949
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23093,80,1.01 [0.82-1.25],0.8942460257507356
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23056,43,1.23 [0.92-1.65],0.1702403270579117
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",22970,76,0.90 [0.73-1.10],0.3003871260625295
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23201,88,0.96 [0.79-1.17],0.6863584877874809
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,23589,110,1.04 [0.87-1.25],0.6574954740643628
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,23013,93,1.01 [0.83-1.22],0.9452403635730754
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Death due to cardiac causes,17410,2362,1.02 [0.98-1.07],0.2863160788588678
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23219,65,0.90 [0.72-1.13],0.3697189514433515
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Hypertension, essential",18329,1734,1.05 [1.00-1.10],0.0664131080973143
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Hypertension,18344,1749,1.05 [1.00-1.10],0.0769247600866283
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,16629,34,0.90 [0.65-1.24],0.5172726559617151
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22275,616,1.03 [0.96-1.12],0.3871109596805436
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Angina pectoris,22086,427,1.01 [0.92-1.11],0.7659378858931731
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23122,123,1.01 [0.85-1.19],0.9404822421885378
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23190,191,1.04 [0.91-1.19],0.5853328763651289
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23637,25,1.07 [0.74-1.54],0.7281579652809631
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",21740,81,1.08 [0.87-1.33],0.4932188365019756
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22043,395,1.06 [0.96-1.16],0.2647591489676334
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Pulmonary embolism,23018,83,1.02 [0.83-1.26],0.8243315057133056
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Venous thromboembolism,23116,185,1.04 [0.90-1.19],0.6016547732554556
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Secondary right heart disease,23025,90,0.88 [0.72-1.06],0.1801495716666714
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23025,90,0.88 [0.72-1.06],0.1801495716666714
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",16682,87,0.91 [0.75-1.11],0.3448658821015085
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Cardiomyopathy,20602,31,1.15 [0.81-1.64],0.4336501232972837
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Conduction disorders,20634,63,1.01 [0.80-1.27],0.956450462119688
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14234,83,1.00 [0.81-1.23],0.9886011572723524
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,14383,232,0.88 [0.78-0.99],0.0386553344625782
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other arrhythmias,20614,43,1.09 [0.82-1.46],0.5486276671565888
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,20620,49,0.82 [0.63-1.05],0.1140792083926411
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Heart failure, strict",22991,85,1.05 [0.85-1.28],0.6664954739865031
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23025,110,0.93 [0.78-1.11],0.4288253894546242
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23061,82,0.95 [0.77-1.16],0.5994313362556826
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23121,70,0.93 [0.75-1.16],0.5415507462058127
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22837,60,0.84 [0.67-1.06],0.1472972338690081
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22872,95,0.88 [0.73-1.06],0.1654387124651972
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22316,112,1.07 [0.90-1.28],0.453154965408972
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,DVT of lower extremities,22293,89,1.07 [0.88-1.31],0.5079205470830082
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23507,88,1.07 [0.88-1.31],0.5001271188512123
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Varicose veins,22728,524,0.90 [0.83-0.97],0.0085520168335568
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Hypotension,22752,73,0.94 [0.76-1.17],0.5704193287652337
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Diseases of the respiratory system,19258,1822,1.04 [0.99-1.09],0.1400359416286331
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23511,113,1.00 [0.84-1.19],0.9832589651803584
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Influenza and pneumonia,22293,179,0.93 [0.81-1.07],0.3133405022770164
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22276,162,0.93 [0.81-1.08],0.3389805360583324
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22900,205,0.98 [0.86-1.11],0.7230165329369098
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22895,200,0.98 [0.86-1.12],0.7592014088003921
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23033,484,1.09 [1.00-1.19],0.0474772694416588
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Chronic sinusitis,22652,103,1.17 [0.97-1.41],0.1053008952192097
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Nasal polyp,22620,71,1.21 [0.96-1.52],0.1142410105255746
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22856,307,1.09 [0.98-1.22],0.1184496173323667
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Deviated nasal septum,22670,121,1.04 [0.88-1.24],0.6339102516492015
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11374,56,1.08 [0.83-1.39],0.5654828544077195
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,21123,1004,1.03 [0.97-1.09],0.3544942855214579
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Early onset COPD,22795,136,1.18 [1.00-1.40],0.0467243757967304
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22812,153,1.10 [0.94-1.28],0.2290975873403429
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",22812,153,1.10 [0.94-1.28],0.2290975873403429
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",21896,859,1.02 [0.96-1.09],0.4996112322789816
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Asthma,17585,859,1.03 [0.96-1.10],0.3874372136722628
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",17425,859,1.03 [0.96-1.10],0.3670650865441457
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",17573,847,1.02 [0.96-1.09],0.4911576813558855
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23412,79,0.90 [0.73-1.10],0.2918815807596355
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Interstitial lung disease,22116,61,0.89 [0.70-1.12],0.3164339945071605
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"ILD, hospital admissions",23474,61,0.89 [0.71-1.12],0.3260578459025325
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22109,54,0.84 [0.66-1.08],0.1746323389115984
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Pleural effusion,22106,74,0.92 [0.74-1.14],0.4500779370235441
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other diseases of pleura,22199,167,0.99 [0.86-1.14],0.8828393568120987
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,22684,79,0.98 [0.80-1.20],0.8329927782281491
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16466,5178,1.01 [0.98-1.04],0.5577766628692032
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23203,406,1.04 [0.95-1.14],0.4013115693369632
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23657,85,1.08 [0.88-1.33],0.4480563983520722
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Impacted teeth,23662,77,1.09 [0.88-1.35],0.4360453713442577
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Dental caries,22891,94,1.02 [0.84-1.23],0.8774695066123727
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22902,105,1.07 [0.89-1.28],0.4982688783041127
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23648,94,1.10 [0.90-1.34],0.3471409384580053
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22892,95,1.09 [0.90-1.32],0.3864706882822877
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22640,66,0.78 [0.63-0.97],0.0252456398681393
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23578,43,0.74 [0.56-0.96],0.0233631362967077
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,17925,192,0.91 [0.80-1.04],0.1560174161032287
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",19727,1994,0.99 [0.94-1.03],0.5435665033273471
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Oesophagitis,17983,250,1.18 [1.05-1.34],0.0075192871749394
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18381,648,1.00 [0.93-1.08],0.975247970323187
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of oesophagus,17800,67,1.06 [0.84-1.33],0.6466325735122671
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17850,117,1.14 [0.95-1.36],0.1545793736283562
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Oesophageal obstruction,17767,34,1.08 [0.77-1.50],0.66114786450071
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gastric ulcer,17861,128,0.87 [0.74-1.02],0.078982934184288
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Duodenal ulcer,17798,65,0.98 [0.78-1.24],0.8969578923550428
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23616,51,0.92 [0.71-1.18],0.4978522231669564
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Chronic gastritis,17847,114,0.96 [0.81-1.15],0.6628460463611576
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18456,723,0.96 [0.89-1.03],0.20860004273301
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of appendix,23555,133,1.08 [0.91-1.27],0.37579618854661
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Functional dyspepsia,18229,496,0.99 [0.91-1.08],0.8028403895797399
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,17883,150,1.02 [0.87-1.19],0.8260576990746539
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23575,125,0.99 [0.84-1.17],0.9266153998087578
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Acute appendicitis,23532,110,1.03 [0.86-1.23],0.7398276544061205
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Hernia,21224,1047,0.99 [0.93-1.05],0.7960915270593046
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Inguinal hernia,20235,58,0.85 [0.67-1.08],0.1889053855408474
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Umbilical hernia,20244,67,1.10 [0.86-1.39],0.4523455636904394
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Ventral hernia,20266,89,0.91 [0.75-1.11],0.3690236080466288
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diaphragmatic hernia,21014,837,1.01 [0.95-1.08],0.7185172204487722
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22760,795,1.03 [0.96-1.10],0.3725585301672814
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of intestines,18800,1885,1.01 [0.97-1.06],0.5359108634713223
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23399,54,0.96 [0.75-1.23],0.7347877596529956
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",23637,77,1.00 [0.81-1.24],0.965371440578292
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Crohn disease,22042,77,1.01 [0.82-1.25],0.9199047483164168
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Crohn's disease NAS,22021,56,0.96 [0.75-1.23],0.7657600630764101
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",23564,112,1.13 [0.95-1.36],0.1736470849697453
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Ulcerative colitis,22077,112,1.14 [0.95-1.36],0.1587978806349786
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22063,98,1.11 [0.92-1.34],0.2905414671272298
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22644,679,1.03 [0.96-1.11],0.3819736940007986
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22634,669,1.03 [0.96-1.11],0.4102830199633759
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17001,86,1.04 [0.85-1.27],0.7133692019974757
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Intestinal stricture,23285,86,1.03 [0.85-1.26],0.7454954822442931
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",16968,53,1.00 [0.77-1.28],0.9723685963673174
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diverticular disease of intestine,17495,580,0.98 [0.90-1.06],0.5573488634102225
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Irritable bowel syndrome,17124,209,1.00 [0.88-1.13],0.9481183930032722
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other functional intestinal disorders,17241,326,1.05 [0.95-1.17],0.3288677726155292
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Constipation,22252,291,1.03 [0.92-1.15],0.6346537829203067
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of peritoneum,23244,104,0.93 [0.78-1.11],0.4275132772034486
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,17025,110,1.07 [0.89-1.28],0.4720063731518346
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16954,39,0.82 [0.62-1.09],0.1770831186815299
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17694,779,1.03 [0.96-1.11],0.3449748264707775
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of intestine,17116,201,0.92 [0.81-1.06],0.2420220032620234
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23230,90,0.94 [0.78-1.14],0.5388214168111316
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of liver,23024,89,0.74 [0.61-0.89],0.0012938619131535
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of liver,22982,47,0.84 [0.64-1.09],0.1822363454993177
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22346,744,1.02 [0.95-1.09],0.6592745677547023
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Cholelithiasis,22224,622,1.01 [0.93-1.09],0.8335752293858563
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Cholecystitis,21716,114,1.08 [0.90-1.28],0.4129164570512248
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21660,58,1.13 [0.88-1.46],0.329452708120988
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Acute pancreatitis,21654,52,0.92 [0.71-1.18],0.495174901670123
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),23556,52,0.91 [0.71-1.17],0.4622711355862494
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of the digestive system,22512,254,1.20 [1.06-1.35],0.0032748348268937
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Intestinal malabsorption,22344,86,1.24 [1.00-1.53],0.0448706238018464
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Coeliac disease,22331,73,1.25 [0.99-1.57],0.0593687252498957
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22292,34,1.19 [0.86-1.66],0.2881679085995722
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22397,139,1.23 [1.04-1.44],0.0146718315532536
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,GI-bleeding,22389,131,1.23 [1.04-1.46],0.014893103680445
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,20972,1385,0.97 [0.92-1.02],0.2475919149490374
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23298,103,0.90 [0.75-1.08],0.2472848428749924
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23311,386,1.00 [0.91-1.10],0.961384072538092
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22323,592,1.02 [0.94-1.10],0.6427740668612305
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22977,284,0.94 [0.84-1.05],0.2947848897223135
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22756,63,0.84 [0.67-1.06],0.142630211630594
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22876,183,0.94 [0.82-1.07],0.3412523746430816
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23435,75,0.94 [0.76-1.17],0.5880971222845169
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23414,54,1.00 [0.78-1.28],0.9849846973184913
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23402,42,0.99 [0.74-1.31],0.9338556747170954
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23472,49,0.93 [0.71-1.21],0.5679158439622475
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23469,46,0.92 [0.70-1.21],0.5642407838920279
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22976,51,1.20 [0.91-1.57],0.1952722424949808
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23225,300,0.98 [0.88-1.09],0.760495859487213
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21817,86,0.97 [0.79-1.18],0.7265415087706555
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21861,130,0.93 [0.79-1.10],0.4095450263135785
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21827,96,0.97 [0.80-1.17],0.7619840543268261
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21950,219,1.02 [0.90-1.16],0.7933559605894079
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21929,198,1.00 [0.87-1.14],0.956014497893976
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,16688,3804,1.01 [0.97-1.04],0.7738409240791077
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,18195,2191,1.02 [0.97-1.06],0.4643459787108636
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21265,1144,1.06 [1.00-1.12],0.05398892140125
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16197,193,1.01 [0.89-1.16],0.8306398743222477
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16456,452,0.99 [0.90-1.08],0.8164285158713709
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23195,185,1.03 [0.90-1.18],0.6696648489918429
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23209,170,1.01 [0.87-1.16],0.9197521420771044
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,17053,1049,1.04 [0.98-1.11],0.1844067096430256
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",19402,1049,1.05 [0.98-1.11],0.1597663572658691
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16016,12,0.70 [0.42-1.15],0.1621857204497379
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23534,12,0.67 [0.40-1.10],0.1113105291243184
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,16235,231,0.99 [0.88-1.12],0.8860194418250886
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16081,77,1.00 [0.80-1.24],0.9753242331001862
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,16268,264,1.08 [0.96-1.22],0.1861852282678813
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23513,134,1.22 [1.03-1.44],0.0220250423931719
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,16412,408,1.07 [0.97-1.18],0.2051339230320684
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,16414,410,1.00 [0.91-1.10],0.982342819815084
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,17230,1226,1.00 [0.94-1.05],0.8747807676539772
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16103,99,1.03 [0.86-1.25],0.7366373243794293
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16364,360,0.94 [0.85-1.04],0.2302771380396905
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16072,68,1.00 [0.79-1.25],0.9666940674304572
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16095,91,1.01 [0.83-1.23],0.9251476887898292
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16325,321,1.00 [0.90-1.11],0.9289030534612552
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16276,272,0.99 [0.88-1.11],0.8618193407928967
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17640,256,1.01 [0.90-1.14],0.8180174040419562
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22965,206,0.90 [0.80-1.03],0.121323504105493
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22842,83,1.15 [0.93-1.42],0.1946981866817992
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20271,76,0.97 [0.78-1.20],0.7884468085513286
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,20462,267,0.91 [0.81-1.02],0.0955186950190292
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,21092,897,0.91 [0.86-0.97],0.0042314909949196
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20379,184,0.91 [0.79-1.04],0.1657738098144155
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20262,67,0.97 [0.77-1.22],0.8003920785692279
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",20911,716,0.92 [0.86-0.98],0.0164013333643765
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20237,42,1.28 [0.95-1.73],0.108659324748306
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20410,215,0.91 [0.80-1.03],0.1173430586387684
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20287,92,0.95 [0.79-1.15],0.6225205398730143
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20270,75,0.99 [0.80-1.23],0.960070084580408
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20325,130,0.82 [0.70-0.96],0.0147858091361345
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20265,70,0.94 [0.75-1.17],0.5572205980450927
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20505,310,0.94 [0.84-1.04],0.2366100865247442
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20454,333,1.04 [0.94-1.15],0.456271135281678
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20184,63,0.98 [0.78-1.24],0.8647344671193058
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20215,94,0.91 [0.75-1.11],0.3554684508588004
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20242,121,1.19 [1.00-1.42],0.0484539174940543
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20157,36,0.93 [0.69-1.27],0.6593970681649334
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20171,50,1.16 [0.89-1.53],0.2730906559435069
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20158,37,1.07 [0.78-1.45],0.6856246004789135
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20349,228,1.09 [0.96-1.23],0.1979919484048131
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20172,51,1.03 [0.79-1.35],0.804712363693062
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20174,53,1.00 [0.77-1.29],0.9861918137120952
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20234,113,1.14 [0.95-1.37],0.1458210323286433
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20190,69,0.97 [0.78-1.21],0.7796345530004518
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20588,467,1.04 [0.95-1.13],0.4379050121802971
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20287,166,0.96 [0.83-1.11],0.5952062966651978
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20374,253,1.01 [0.90-1.14],0.8397648572162758
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,21323,212,0.91 [0.80-1.03],0.1312030977286704
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,21526,415,0.88 [0.81-0.97],0.0069686932412081
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,21145,34,1.04 [0.76-1.43],0.7975095670385223
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,21160,49,0.85 [0.66-1.10],0.2133342206960036
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21202,91,0.86 [0.71-1.03],0.1065370847668529
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,19446,5297,0.98 [0.95-1.01],0.2145103274637838
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,21698,158,1.01 [0.87-1.18],0.8458082438777053
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21579,39,1.36 [0.99-1.87],0.055720560456216
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Acute renal failure,21863,26,0.98 [0.69-1.41],0.9278513828206244
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21867,30,0.97 [0.69-1.36],0.8428275298638268
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21870,33,0.99 [0.72-1.37],0.9672982419127923
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Urolithiasis,23484,109,0.97 [0.81-1.15],0.699676844741034
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23387,53,1.13 [0.87-1.48],0.3600303542317848
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23457,82,0.97 [0.79-1.19],0.7471858155535582
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23406,31,0.98 [0.70-1.37],0.9138179778171684
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,21822,1091,1.01 [0.96-1.08],0.6294850510577668
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Cystitis,20840,109,0.93 [0.78-1.10],0.3974896185687763
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20807,76,1.18 [0.94-1.46],0.1466383710596289
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,20872,141,1.01 [0.86-1.18],0.9045817367048536
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Urethral stricture,20812,81,0.86 [0.70-1.05],0.1322177960754679
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21594,863,1.03 [0.96-1.10],0.3765367321185121
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Disorders of breast,23431,416,0.91 [0.83-1.00],0.042863384976954
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,23145,130,0.91 [0.78-1.07],0.2783541585457708
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,23159,144,0.97 [0.83-1.13],0.6947538862516238
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of breast,23113,98,0.83 [0.69-0.99],0.0397433687437688
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23369,484,1.00 [0.91-1.08],0.9124866160232542
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,23003,118,0.98 [0.83-1.16],0.8074826589938604
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,23100,215,1.02 [0.90-1.16],0.7736654755612399
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,21619,3960,0.99 [0.96-1.02],0.4628295224840447
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Endometriosis,17960,301,1.05 [0.94-1.18],0.3605828178440123
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,17741,82,1.29 [1.04-1.61],0.0209741416437229
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17801,142,1.01 [0.86-1.18],0.940066819951304
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18345,686,1.05 [0.97-1.13],0.2081229087467394
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Ovarian cyst,18008,349,0.94 [0.85-1.04],0.2023904265186383
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18480,821,0.96 [0.89-1.02],0.1739258366812368
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Uterine polyps,17928,269,0.89 [0.80-1.00],0.0497765938397384
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",18039,380,1.01 [0.92-1.12],0.8046684586483721
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,17747,88,1.17 [0.95-1.43],0.141767472183317
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,17827,168,1.07 [0.92-1.24],0.3696305386804084
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",23657,229,1.09 [0.96-1.24],0.1623795748658978
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,23668,217,1.10 [0.96-1.25],0.1630150723050124
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,23689,116,1.21 [1.01-1.44],0.0426460370226282
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",23679,128,1.19 [1.00-1.42],0.0449036347611908
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17787,128,0.92 [0.78-1.08],0.3237145197451905
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17763,104,0.96 [0.80-1.15],0.6591339128441683
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17783,124,1.01 [0.85-1.19],0.9349282529468464
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Irregular menses,23602,398,1.11 [1.01-1.22],0.0332279102224435
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",18822,1163,1.02 [0.96-1.08],0.474696912008683
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Menorrhagia,18423,764,0.99 [0.93-1.06],0.8146438060901651
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",23677,173,1.02 [0.88-1.17],0.8035476381467883
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,18061,402,0.96 [0.88-1.05],0.398473531717694
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17928,269,0.95 [0.85-1.07],0.4168257038786778
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18433,774,0.93 [0.87-1.00],0.0485259816512635
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Female infertility,17742,83,1.11 [0.89-1.38],0.3469533834722135
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",17735,76,1.08 [0.86-1.35],0.5063236516344914
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,23684,720,1.00 [0.93-1.08],0.9542381207330072
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,23690,987,1.03 [0.96-1.11],0.3479160681904476
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,23684,380,1.13 [1.02-1.26],0.0179811166559835
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,23411,107,1.16 [0.96-1.40],0.1272956421562432
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,23452,148,1.02 [0.87-1.19],0.8421996249837328
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,23441,137,1.30 [1.09-1.54],0.0029756223489077
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",23701,143,0.97 [0.83-1.13],0.6965656069179713
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,23703,140,0.97 [0.83-1.14],0.7553330362083979
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,23701,353,0.91 [0.82-1.01],0.0913748923309053
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,23453,105,0.81 [0.68-0.97],0.0243038312621905
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,23544,196,0.94 [0.82-1.08],0.361390314953625
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,23087,123,1.07 [0.89-1.27],0.4716550910734894
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,23130,166,1.01 [0.87-1.18],0.8517763268037024
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,23165,201,0.99 [0.86-1.13],0.8399336606415466
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,23086,122,0.99 [0.83-1.17],0.8692163804348224
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",False labour,23076,112,1.09 [0.91-1.31],0.3626117290165408
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,23090,126,0.87 [0.74-1.03],0.1106270097097914
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Long labour,22887,184,1.09 [0.94-1.25],0.2603125099219425
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],23068,365,1.02 [0.92-1.13],0.7368983564357727
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,23251,548,1.08 [0.99-1.18],0.0785598508093881
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",23705,144,1.04 [0.88-1.22],0.6578829584530714
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,22508,110,1.02 [0.85-1.22],0.8111601211100824
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",22787,84,1.01 [0.82-1.25],0.90750898032312
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Delivery,23711,279,0.93 [0.83-1.05],0.2510245885885158
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,23648,216,0.93 [0.81-1.06],0.2637468084022288
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",23700,214,1.06 [0.93-1.22],0.377662232346636
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",23690,204,1.06 [0.92-1.21],0.4332062128703424
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23453,40,0.95 [0.71-1.27],0.7100231279707895
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Falls/tendency to fall,21226,531,0.88 [0.82-0.96],0.0023966227445809
